All Stories

  1. Fast quantitative susceptibility mapping using 3D EPI and total generalized variation
  2. Brain Magnetic Resonance Imaging Findings Fail to Suspect Fabry Disease in Young Patients With an Acute Cerebrovascular Event
  3. Morphological MRI Characteristics of Recent Small Subcortical Infarcts
  4. Les hypersignaux de la substance blanche sont-ils liés à de l’œdème cérébral dans les maladies des petites artères cérébrales ?
  5. R2* mapping for brain iron: associations with cognition in normal aging
  6. Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis
  7. Association between increased magnetic susceptibility of deep gray matter nuclei and decreased motor function in healthy adults
  8. Functional Connectivity Analyses Using Emulated and Conventional Resting-State Data: Parts Versus the Whole Story
  9. White Matter Edema at the Early Stage of Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
  10. Magnetization Transfer Ratio Relates to Cognitive Impairment in Normal Elderly
  11. In Vivo High-Resolution 7 Tesla MRI Shows Early and Diffuse Cortical Alterations in CADASIL
  12. Loss of Venous Integrity in Cerebral Small Vessel Disease: A 7-T MRI Study in Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
  13. Repetitive Long-Term Hyperbaric Oxygen Treatment (HBOT) Administered after Experimental Traumatic Brain Injury in Rats Induces Significant Remyelination and a Recovery of Sensorimotor Function
  14. Strategic white matter tracts for processing speed deficits in age-related small vessel disease
  15. Determinants of iron accumulation in deep grey matter of multiple sclerosis patients
  16. Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
  17. Iron mapping using the temperature dependency of the magnetic susceptibility
  18. Brain Activity Changes in Cognitive Networks in Relapsing-Remitting Multiple Sclerosis – Insights from a Longitudinal fMRI Study
  19. Tracking of Magnetite Labeled Nanoparticles in the Rat Brain Using MRI
  20. Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry
  21. MRI in acute cerebral ischemia of the young: The Stroke in Young Fabry Patients (sifap1) Study
  22. Connectivity patterns obtained by emulated vs. conventional resting state fMRI in clinical cohorts —/INS; Can parts tell the whole story?
  23. Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
  24. Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan
  25. MRI for Iron Mapping in Alzheimer's Disease
  26. Microstructural tissue damage in normal appearing brain tissue accumulates with Framingham Stroke Risk Profile Score: Magnetization transfer imaging results of the Austrian Stroke Prevention Study
  27. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease
  28. Erratum: Common variants at 6q22 and 17q21 are associated with intracranial volume
  29. Erratum: Common variants at 12q15 and 12q24 are associated with infant head circumference
  30. Temperature-induced changes of magnetic resonance relaxation times in the human brain: A postmortem study
  31. Multicenter R2* mapping in the healthy brain
  32. Quantitative Susceptibility Mapping in Multiple Sclerosis
  33. Clinical effects of electroconvulsive therapy in severe depression and concomitant changes in cerebral glucose metabolism—An exploratory study
  34. Brain atrophy and lesion load predict long term disability in multiple sclerosis
  35. Diffusion changes predict cognitive and functional outcome: The LADIS study
  36. Temperature Dependency of T1 Relaxation Time in Unfixed and Fixed Human Brain Tissue
  37. Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model
  38. B Vitamins and Magnetic Resonance Imaging-Detected Ischemic Brain Lesions in Patients With Recent Transient Ischemic Attack or Stroke: The VITAmins TO Prevent Stroke (VITATOPS) MRI-Substudy
  39. Levodopa changes brain motor network function during ankle movements in Parkinson’s disease
  40. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study
  41. CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
  42. Abnormalities of Resting State Functional Connectivity Are Related to Sustained Attention Deficits in MS
  43. Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis
  44. Erratum: Common variants at 6q22 and 17q21 are associated with intracranial volume
  45. Common variants at 6q22 and 17q21 are associated with intracranial volume
  46. Common variants at 12q15 and 12q24 are associated with infant head circumference
  47. The spatial distribution of age-related white matter changes as a function of vascular risk factors—Results from the LADIS study
  48. Susceptibility induced gray–white matter MRI contrast in the human brain
  49. Vascular Risk Factors, White Matter Hyperintensities and Hippocampal Volume in Normal Elderly Individuals
  50. White matter hyperintensities alter functional organization of the motor system
  51. Longitudinal Magnetization Transfer Imaging in Mild to Severe Alzheimer Disease
  52. Determinants of brain iron in multiple sclerosis: A quantitative 3T MRI study
  53. Heterogeneity in age-related white matter changes
  54. MRI assessment of iron deposition in multiple sclerosis
  55. Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
  56. The functional correlates of face perception and recognition of emotional facial expressions as evidenced by fMRI
  57. Altered functional organization of the motor system related to ankle movements in Parkinson’s disease: insights from functional MRI
  58. Fast bound pool fraction mapping using stimulated echoes
  59. Relaxation time mapping in multiple sclerosis
  60. MRI-detected white matter lesions: do they really matter?
  61. Reorganization in cognitive networks with progression of multiple sclerosis: Insights from fMRI
  62. Predicting the severity of relapsing-remitting MS: The contribution of cross-sectional and short-term follow-up MRI data
  63. Basilar Artery Diameter Is a Potential Screening Tool for Fabry Disease in Young Stroke Patients
  64. Protocol and Methodology of the Stroke in Young Fabry Patients (sifap1) Study: A Prospective Multicenter European Study of 5,024 Young Stroke Patients Aged 18–55 Years
  65. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis
  66. Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study 1
  67. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome
  68. Super-resolution MRI using microscopic spatial modulation of magnetization
  69. Metabolic Syndrome, Brain Magnetic Resonance Imaging, and Cognition
  70. Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration?
  71. Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis
  72. Intercenter differences in diffusion tensor MRI acquisition
  73. The Impact of Sex and Vascular Risk Factors on Brain Tissue Changes with Aging: Magnetization Transfer Imaging Results of the Austrian Stroke Prevention Study
  74. Diffusion-Weighted Imaging and Cognition in the Leukoariosis and Disability in the Elderly Study
  75. MRI in Dementia
  76. Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis
  77. High-Grade Internal Carotid Artery Stenosis and Chronic Brain Damage: A Volumetric Magnetic Resonance Imaging Study
  78. Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study
  79. Gender differences in MRI studies on multiple sclerosis
  80. Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study
  81. A new combined fMRI paradigm to study the neural correlates of the perception of faces and the recognition of emotional facial expression
  82. fMRI evidence for functional reorganisation in cognitive networks with disease progression in Multiple Sclerosis
  83. Quantifying the influence of perfusion changes due to vessel abnormalities on functional-MRI
  84. Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis
  85. Brain Activity Changes Associated With Treadmill Training After Stroke
  86. Short-term adaptation to a simple motor task: A physiological process preserved in multiple sclerosis
  87. MRI in Dementia
  88. Magnetization Transfer MR Imaging in Multiple Sclerosis
  89. Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: The LADIS (leukoaraiosis and disability in the elderly) study
  90. Assessment of Iron Concentration by Direct Saturation Imaging (DSI) in a Two- Pool Model of Brain Tissue
  91. Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
  92. Reproducibility of fMRI in the clinical setting: Implications for trial designs
  93. Brain motor system function in a patient with complete spinal cord injury following extensive brain–computer interface training
  94. P2-074: Effects of memantine on brain volume, glucose metabolism and cognition in Alzheimer's disease patients: A neuroimaging study
  95. Transient Global Amnesia: Diffusion-Weighted Imaging Lesions and Cerebrovascular Disease
  96. Segmentation of age-related white matter changes in a clinical multi-center study
  97. Brain activation patterns elicited by the `Faces Symbol Test' — a pilot fMRI study
  98. Functional MRI Correlates of Lower Limb Function in Stroke Victims With Gait Impairment
  99. Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition
  100. Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study
  101. Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
  102. Progression of Leukoaraiosis and Cognition
  103. Progression of cerebral white matter lesions — Clinical and radiological considerations
  104. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease
  105. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX
  106. C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study
  107. IC-P-019
  108. P2-378
  109. Subcortical vascular cognitive impairment: Similarities and differences with multiple sclerosis
  110. The impact of our genes: Consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis
  111. Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: An fMRI study
  112. Lesion probability maps of white matter hyperintensities in elderly individuals
  113. Measurement of short and ultrashortT2 components using progressive binomial RF saturation
  114. Relapsing acute transverse myelitis: a specific entity
  115. MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)
  116. Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects
  117. Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H—magnetic resonance spectroscopy
  118. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging
  119. Foundations of advanced magnetic resonance imaging
  120. White matter lesion progression, brain atrophy, and cognitive decline: The Austrian stroke prevention study
  121. European Study on Intravenous Immunoglobulin in Multiple Sclerosis
  122. Acupuncture using laser needles modulates brain function: first evidence from functional transcranial Doppler sonography and functional magnetic resonance imaging
  123. Normal-Appearing White Matter Changes in Multiple Sclerosis: Magnetization Transfer
  124. Midbrain Ischemia Presenting as Vertical Gaze Palsy: Value of Diffusion-Weighted Magnetic Resonance Imaging
  125. Accelerated evolution of brain atrophy and ?black holes? in MS patients withAPOE-?4
  126. Assessment and correction ofB1-induced errors in magnetization transfer ratio measurements
  127. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study
  128. Method for quantitative imaging of the macromolecular1H fraction in tissues
  129. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis
  131. Lower Levels of N-Acetylaspartate in Multiple Sclerosis Patients With the Apolipoprotein E ϵ4 Allele
  132. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis
  133. TACE mRNA expression in peripheral mononuclear cells precedes new lesions on MRI in multiple sclerosis
  134. The natural course of MRI white matter hyperintensities
  135. Can small-vessel disease-related cerebral abnormalities be used as a surrogate marker for vascular dementia trials?
  136. Risk factors and progression of small vessel disease-related cerebral abnormalities
  137. CT and MRI rating of white matter changes
  138. T1 maps from shifted spin echoes and stimulated echoes
  139. Estimation of magnetization transfer rates from PACE experiments with pulsed RF saturation
  140. Novel imaging technologies in the assessment of cerebral ageing and vascular dementia
  141. Estimation of magnetization transfer rates from PACE experiments with pulsed RF saturation
  142. Fast multislice T1 and T1sat imaging using a phase acquisition of composite echoes (PACE) technique
  143. Diffusion-weighted Imaging with Navigated Interleaved Echo-planar Imaging and a Conventional Gradient System1
  144. T1 imaging using phase acquisition of composite echoes
  145. T1 imaging using phase acquisition of composite echoes
  146. Hochaufgelöste diffusionsgewichtete MRT mit Multishot EPI und Phasennavigation bei zerebralen Ischämien
  147. Nichtinvasive MR-Perfusionsbildgebung im Hirngewebe mittels Magnetisierungspräparation
  148. Binding of antibodies to functional epitopes on the pore formed by Escherichia coli hemolysin in cells and model membranes
  149. Nichtinvasive Bestimmung der Perfusion im Hirngewebe mittels Kernspintomographie
  150. White matter changes
  151. Conventional brain imaging of white matter lesions